Why ISO 22196 creates confusion for hospital retail blankets
A hospital gift shop blanket is still a consumer retail textile, not automatically a healthcare textile for institutional laundering or infection-control use. That distinction affects claim scope, testing fit, care-label assumptions, and importer risk. A soft throw sold beside flowers and snacks is sourced, labelled, packed, and claimed very differently from a ward blanket that must survive industrial wash chemistry, traceable reprocessing, and institutional performance standards.
The core technical point is simple: ISO 22196 measures antibacterial activity on plastics and other non-porous surfaces. It uses a wet inoculum, close film contact, controlled humidity, and typically 24-hour incubation to compare viable counts on treated and untreated control surfaces. Those conditions can favour apparent activity on treated smooth surfaces. Raised polyester microfleece is different: it is porous, pile-bearing, compressible, and variable in contact area and wet pick-up. Using ISO 22196 alone on brushed fleece is therefore a weak fit for end use such as dry, intermittent blanket contact.
The sourcing consequence is practical. Do not use ISO 22196 alone to support finished-blanket retail claims on microfleece. At most, it may support a narrow material-level statement if the tested specimen is production-representative and the wording stays close to the report. If you need evidence aligned to textile substrates, request ISO 20743 evidence and tie it to physical QC, SKU release, and artwork approval. Related reading: blanket quality control inspection and AQL 2.5 inspection checklist.
ISO 22196 versus ISO 20743: which method fits a fleece blanket
Buyers should stop treating ISO 22196 and ISO 20743 as interchangeable. ISO 22196 is designed for non-porous treated surfaces. ISO 20743 is the textile antibacterial method family and is usually the more relevant basis for a 240gsm brushed polyester microfleece blanket because it addresses textile substrates, textile inoculation, and textile recovery behaviour.
Ask the lab which ISO 20743 method option was used. Depending on textile construction and intended use, labs may use the absorption method, transfer method, or printing method. For raised microfleece, method selection matters because pile depth, absorbency, and surface openness affect inoculum distribution and recovery. A supplier saying only "tested to ISO 20743" is not enough; the report should identify the variant used, the organisms tested, and whether testing was done before and after laundering.
A practical rule for buyers: if the evidence is meant to support wording about the treated textile article, ISO 20743 on production-representative fleece is usually the stronger file. If a chemistry supplier also provides ISO 22196 data, keep it as supplementary chemistry-support information, not as the release basis for consumer-facing blanket claims. If the mill cannot provide textile-specific evidence, remove antibacterial wording from packaging and PDP copy.
What ISO 22196 and ISO 20743 can support, and where they should stop
Both ISO 22196 and ISO 20743 are antibacterial tests. They are not antiviral, not antifungal unless separately tested, and not evidence of infection prevention, disease prevention, or user protection. Buyers should state that boundary internally and in copy review comments because claim creep usually starts with marketing teams extending "antibacterial" into "safer," "protective," or "hospital-grade" language.
Used conservatively, a report may support wording such as "treated fabric showed antibacterial activity against specified test organisms under laboratory conditions" or "antibacterial finish intended to protect the treated article", subject to destination-market legal review. It does not support broad finished-product claims such as "antibacterial blanket," "kills germs everywhere," "protects patients," "prevents infection," or "medical protection."
A factual composition statement is lower risk than a performance claim. "Silver-based finish applied to polyester microfleece" describes treatment. "Protects the user" or "hygienic blanket" implies in-use benefit. If the evidence only covers the fleece face under lab conditions, keep the wording at that level or drop the claim entirely. Related regulatory framing is easier to manage if the copy is limited to article protection rather than user benefit.
How to read the result metric without overselling it
If a supplier cites ISO 22196, ask for the original numerical result, not only a headline such as "99% antibacterial." The standard reports an antibacterial activity value R. In practical terms, R is the logarithmic difference between the viable bacterial count recovered from the untreated control specimen and the treated specimen after the specified contact period, commonly 24 hours, under the test conditions. Higher R indicates greater reduction versus the untreated control in that laboratory setup.
That does not mean the blanket gives continuous real-world protection, nor does it convert cleanly into a blanket-wide consumer promise. A claim based on R is only as good as the match between the tested article and the sold article, the control used, the organisms named, and the wash state. Buyers should keep the original expression in the technical file and avoid inflating it into aggressive front-of-pack language.
Also remember that efficacy is organism-specific. Results against Staphylococcus aureus and Klebsiella pneumoniae, which are common named organisms in antibacterial reports, do not generalise to all bacteria, fungi, or viruses. Many brands set an internal threshold such as R ≥ 2.0 after agreed wash cycles before even considering limited copy, but that is a commercial acceptance rule, not a universal legal pass/fail. The report should show the untreated control was the same fleece construction without the antibacterial finish, not a different flat polyester reference fabric.
Regulatory framing by market: protect the article, not the user
For US-bound retail, review whether the wording stays within typical treated article boundaries. Safer claim direction is usually limited to protecting the treated product itself, for example controlling bacterial growth on the treated fabric surface. Higher-risk wording is anything implying benefit to the user, patient, caregiver, or indoor environment. Packaging, hangtags, PDP bullets, Amazon A+ copy, and carton stickers all count as claims.
For EU-bound retail, check whether the finish and intended wording trigger treated-article issues under the Biocidal Products Regulation. The active substance status, supplier documentation, destination market, and advertising language need to line up. A lawful chemistry supply chain does not automatically clear the consumer claim. Importer-of-record risk and marketplace copy should be reviewed together, not separately, because the listing text often creates the real exposure.
Useful internal copy examples for non-technical teams: Unacceptable: "Protects you from bacteria." Lower-risk rewrite: "Treated fabric is designed to inhibit growth of certain bacteria on the article under laboratory conditions." Unacceptable: "Infection-prevention blanket." Lower-risk rewrite: "Silver-based finish applied to the fleece face; no medical or infection-prevention claim."
Silver chemistry is not one thing: what buyers should distinguish
Suppliers often say "silver-ion finish" as if all systems behave the same. They do not. Terms such as silver ion, silver zeolite, silver glass, and nanosilver are commercially common but too imprecise for sourcing approval. Performance, wash retention, handle, shade shift, and regulatory review depend on the full formulation and application route, not only the silver label.
Ask for the actual chemistry package as far as the supplier can disclose: active substance description, finish code, version or revision number, binder system, catalyst or crosslinker if used, target wet pick-up or add-on range, curing temperature and dwell, and compatibility with softener or anti-pilling finishes. On microfleece around 240gsm, a silver finish can alter handfeel, pile openness, or shade depth if binder load is too high. Pale greys and whites often show chemistry-related cast more clearly than dark navy or charcoal shades.
From a commercial angle, chemistry choice affects MOQ, line setup, retest burden, and repeatability. A mill may hold one standard recipe for core colours and another for soft-hand or low-odour requirements. If the supplier cannot identify more than "antibacterial agent added," or cannot lock the finish code on the PO and bulk approval card, do not approve antibacterial copy.
What report data matters before you approve copy
A usable report needs more than a brochure line saying "99% antibacterial." Ask for the full lab report. Minimum fields should include laboratory name, accreditation status or equivalent competence evidence, report number, issue date, standard cited exactly, method option where relevant, sample receipt date, specimen description, organisms tested, incubation time, recovery method, and whether the result is pre-wash or post-wash. Many buyers treat reports older than about 12 to 24 months as stale unless the construction, finish code, plant, and process controls are unchanged.
Then check report-to-SKU linkage against a hard checklist. At minimum, the tested article should match: fiber content, face construction or pile type, basis weight in gsm, finish code and revision, colour, production plant, wash count, care program, and intended claim wording. For finished blankets, also match binding type, embroidery or print process, patch application, accessory materials, and final packaging if those elements are part of the claimed SKU. A fabric-only report on plain grey fleece is not enough if the sold item is a bound, embroidered, printed, gift-packed blanket.
Ask one more question that is often missed: was the untreated control the same fleece construction without the antibacterial treatment? If the control was a different substrate, different gsm, or flat polyester rather than raised microfleece, the comparison is weaker. Related QC linkage work is easier if the PO also references the approved BOM and care label standard; see ISO 3758 care labeling and blanket care washing guide.
Material-level evidence is not finished-SKU evidence
Buyers should separate material-level substantiation from finished-SKU substantiation. Material-level evidence might cover only the fleece face before cutting. Finished-SKU evidence is broader: it concerns the actual sellable article with cutting, sewing, overlock or binding, printing, embroidery, patches, straps, belly bands, and final care instructions. Claim scope should follow the weaker of the two evidence sets, not the stronger marketing headline.
This matters because mixed constructions can change performance and claim risk. If only the fleece panel is treated, you cannot imply the entire blanket package, edge binding, or carrier strap has antibacterial performance. If screen print, foil, embossing, silicone patching, or laminated labels were added after finishing, they may change the exposed surface area and make a fabric-only report less representative. A blanket with overlocked edges and paper belly band is still a different article from an uncut lab swatch.
A workable commercial rule is: fabric claim supports fabric wording; finished-product claim needs finished-product substantiation or very narrow wording approved by compliance. If the blanket is sold through hospital retail, pharmacy chains, marketplaces, or gift shops with strict product-detail-page controls, use the finished SKU as the substantiation target wherever possible.
Define evidence tiers before you talk about claims
Buyers should separate four evidence tiers before packaging review starts. Tier 1: chemical supplier demo panel or generic swatch. Tier 2: mill pilot fabric, lab-dip, or strike-off. Tier 3: bulk production fabric representative of the approved lot. Tier 4: finished SKU sampled from production, with the same sewing, print, trims, care label, and packaging configuration as the sold article.
Tier 1 is useful for screening chemistry but not for claim approval. Tier 2 can support development decisions and handfeel-risk assessment. Tier 3 is the minimum many buyers accept for a narrow fabric-level statement if the finish code, gsm, colour, and plant all match bulk. Tier 4 is the safest basis if you want any consumer-facing wording on a retail blanket.
Write the evidence tier into the sourcing file and PO. That prevents the common problem where a development-stage report is recycled for repeat orders after gsm, brushing depth, or finishing sequence has changed. For repeat programs, require confirmation that the same plant, same finish revision, and same testing basis still apply before reusing old reports.
Durability must be agreed in the PO, not argued after testing
Antibacterial performance without wash-durability agreement is commercially weak. Buyers should pre-agree the laundering protocol, number of cycles, and post-wash acceptance rule in the PO before bulk starts. For home-care blankets, a common reference is ISO 6330 domestic laundering with the exact wash procedure, detergent assumptions if relevant, drying method, and cycle count stated on the test request and PO. Related wash-fastness controls can be aligned with ISO 105-C06 wash fastness testing where colour durability is also under review.
Do not accept vague wording such as "durable after washing." State the exact commercial requirement, for example: test after 5, 10, or 20 home-laundry cycles; no claim use unless antibacterial result remains at or above the agreed internal threshold; handfeel and shade change must remain within approved bulk standard. If the blanket is likely to be washed warm, tumble dried, or line dried inconsistently by end users, align the protocol to the care label you actually print, not to a gentler lab routine.
A practical PO checklist is short and effective: wash standard, wash procedure code, number of cycles, specimen state before test, organism set, acceptance threshold, report issue requirement, retest trigger after finish revision, and who pays for retesting if bulk fails. If these items are absent, expect arguments at artwork stage or after first repeat order.
Commercial red flags in supplier submissions
Several submission patterns should slow approval immediately. Red flag 1: only a chemistry-brand brochure, no mill-specific or SKU-specific report. Red flag 2: report on flat woven or flat knitted polyester, not raised microfleece. Red flag 3: specimen gsm, colour, or finish revision does not match your approved blanket. Red flag 4: report does not identify the organism names, method option, or wash state.
More subtle red flags include reports issued by a lab with unclear competence, very old reports reused across multiple plants, controls that are not the same untreated fleece construction, or summaries showing only a marketing percentage without raw counts or R value. Also question any submission where the final blanket has printing, embroidery, patching, or mixed-material trims but the evidence covers only unfinished greige fleece.
If the mill submits a report on 200gsm flat polyester while your SKU is 240gsm raised microfleece with overlock edge and belly band, treat that as non-matching evidence, not "close enough." The same caution applies if the lab sample is white and the bulk is black or navy, because dyeing and finishing sequence can affect chemistry deposition and wash retention.
Practical buyer checklist for PO, artwork, and shipment release
Before PO release, lock these fields: 240gsm polyester microfleece target with tolerance, pile/face description, colour standard, silver-finish code and revision, plant, claim wording draft, wash protocol, test method, organism list, and acceptance threshold. If the program is retail-packaged, also lock care label wording, hangtag copy, and importer compliance review responsibility.
Before artwork approval, confirm the final copy stays within the evidence. Good discipline is to compare every antibacterial phrase against the report and mark whether it refers to the article, the user, or a medical outcome. Only article-protection wording tied to the tested conditions should survive. If the copy drifts, rewrite or delete it. For broader blanket program controls, see custom blanket lead times and shipping and how to specify blanket programs for PO discipline models.
Before shipment release, use normal textile QC plus claim-specific checks: confirm correct care label version, packaging version, lot traceability, finish-code traceability, and AQL sampling on workmanship. Claim substantiation is not a substitute for physical QC. On fleece blankets, still inspect gsm consistency, pile defects, bowing, skew, seam security, loose threads, needle damage, odour, and carton marking accuracy.
Frequently asked
Can ISO 22196 alone support an "antibacterial blanket" claim on 240gsm microfleece? Usually no. ISO 22196 is a non-porous surface method and is a weak fit for raised porous microfleece. For blanket-level retail copy, buyers should prefer production-representative ISO 20743 textile evidence plus agreed wash durability. If only ISO 22196 is available, keep any statement narrow, material-level, and legally reviewed.
What should buyers ask for on an ISO 20743 report? Ask for the exact ISO 20743 method option used, named organisms, pre- or post-wash state, specimen description, gsm, fibre content, colour, finish code, plant, issue date, and the untreated control description. For microfleece, the report should match the actual raised fleece construction, not a flat polyester substitute.
Are ISO 22196 or ISO 20743 evidence for antiviral or infection-prevention claims? No. They are antibacterial methods. They do not by themselves support antiviral, antifungal, infection-prevention, patient-protection, or medical-benefit claims. Those directions need separate substantiation and legal review, and often should be avoided on retail blankets.
What is a sensible wash-durability requirement to put in the PO? State the exact laundering standard, procedure, and cycle count in the PO, often using ISO 6330 for home-laundry simulation. Many buyers set an internal requirement such as maintaining the agreed antibacterial result after 5, 10, or 20 cycles, but the right number depends on channel, care label, and claim ambition. Also define post-wash handfeel and colour acceptance.
What are the biggest red flags in supplier antibacterial submissions? Common problems are chemistry-brand brochures without mill-specific reports, reports on flat polyester instead of raised microfleece, mismatched gsm or colour, no named organisms, no wash-state disclosure, or controls that are not the same untreated fleece construction. Any of those gaps should block claim approval until corrected.
Have a project in mind? Send us your spec — we'll reply within one business day with indicative pricing and a sample plan.